REGULATORY ISSUES

   FDA

FDA Drug Approval Summary: Erlotinib (Tarceva^®) Tablets

Martin H. Cohen, John R. Johnson, Yeh-Fong Chen, Rajeshwari Sridhara, Richard Pazdur
The Oncologist 2005; 10: 461-466 ; doi:10.1634/theoncologist.10-7-461
[Abstract] [Full Text] [PDF]  

The Current Situation: Erlotinib (Tarceva^®) and Gefitinib (Iressa^®) in Non-Small Cell Lung Cancer

Robert L. Comis
The Oncologist 2005; 10: 467-470 ; doi:10.1634/theoncologist.10-7-467
[Full Text] [PDF]  

A Review of the Diagnosis and Management of Male Breast Cancer

Sharon H. Giordano
The Oncologist 2005; 10: 471-479 ; doi:10.1634/theoncologist.10-7-471
[Abstract] [Full Text] [PDF]  

Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time?

Wolfgang Janni, Brigitte Rack, Kristina Lindemann, Nadia Harbeck
The Oncologist 2005; 10: 480-492 ; doi:10.1634/theoncologist.10-7-480
[Abstract] [Full Text] [PDF]  

Second Field Tumors: A New Opportunity for Cancer Prevention?

Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff, C. René Leemans
The Oncologist 2005; 10: 493-500 ; doi:10.1634/theoncologist.10-7-493
[Abstract] [Full Text] [PDF]  

Diagnostic Value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 Assays in Pleural Effusions: Analysis of 116 Cases and Review of the Literature

David Shitrit, Boris Zingerman, Ariella Bar-Gil Shitrit, Dekel Shlomi, Mordechai R. Kramer
The Oncologist 2005; 10: 501-507 ; doi:10.1634/theoncologist.10-7-501
[Abstract] [Full Text] [PDF]  

ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty

Richard J. Gilbertson
The Oncologist 2005; 10: 508-517 ; doi:10.1634/theoncologist.10-7-508
[Abstract] [Full Text] [PDF]  

Rhabdomyosarcoma: New Windows of Opportunity

Philip P. Breitfeld, William H. Meyer
The Oncologist 2005; 10: 518-527 ; doi:10.1634/theoncologist.10-7-518
[Abstract] [Full Text] [PDF]  

Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges

Ali Mahdavi, Bradley J. Monk
The Oncologist 2005; 10: 528-538 ; doi:10.1634/theoncologist.10-7-528
[Abstract] [Full Text] [PDF]  

Management of Cancer-Related Anemia with Erythropoietic Agents: Doubts, Certainties, and Concerns

Roberto Stasi, Sergio Amadori, Timothy J. Littlewood, Edmondo Terzoli, Adrian C. Newland, Drew Provan
The Oncologist 2005; 10: 539-554 ; doi:10.1634/theoncologist.10-7-539
[Abstract] [Full Text] [PDF]  

The Molecular Perspective: RAD51 and BRCA2

David S. Goodsell
The Oncologist 2005; 10: 555-556 ; doi:10.1634/theoncologist.10-7-555
[Full Text] [PDF]  

Marcos

Joseph J. Fins
The Oncologist 2005; 10: 557 ; doi:10.1634/theoncologist.10-7-557
[Full Text] [PDF]  

One at a Time

Joel Siegel
The Oncologist 2005; 10: 558-560 ; doi:10.1634/theoncologist.10-7-558
[Full Text] [PDF]  

Reflections

Margaret Mathes, Jason Mathes, M. Hossein Tirgan
The Oncologist 2005; 10: 559-560 ; doi:10.1634/theoncologist.10-7-559
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.